CD99(C1G2),MMab
CD99 is a transmembrane glycoprotein formed by O-glycosylation of a 28 kDa precursor, resulting in a mature molecule of approximately 32 kDa. It is distributed in lymphocytes, thymic cortical cells, ovarian granulosa cells, pancreatic islet cells, and Sertoli cells of the testis. CD99 is currently used primarily in the differential diagnosis of Ewing sarcoma, primitive neuroectodermal tumors, and small round cell tumors that may occur in childhood. It is also useful in the differential diagnosis of thymic epithelial tumors.
In cases where CD20 expression is lost following anti-CD20 therapy, CD79a remains positive. It is mainly usedin combination with other antibodies for the diagnosis of B-cell lymphomas.
Intended Use
CD99 is a transmembrane glycoprotein formed by O-glycosylation of a 28 kDa precursor, resulting in a mature molecule of approximately 32 kDa. It is distributed in lymphocytes, thymic cortical cells, ovarian granulosa cells, pancreatic islet cells, and Sertoli cells of the testis. CD99 is currently used primarily in the differential diagnosis of Ewing sarcoma, primitive neuroectodermal tumors, and small round cell tumors that may occur in childhood. It is also useful in the differential diagnosis of thymic epithelial tumors.
Storage & Validity
Store at 2~8°C. Avoid freezing.
Maintain temperature below room temperature during transport, ensuring it does not exceed one week.
Specifications
| Product Name | CD99(C1G2),MMab |
| Clone | C1G2 |
| Catalog No. | CCM-0742 |
| Positive Site | Cytoplasm, Membrane |
| Applicable Tissue | Paraffin section |
| Pre-treatment | Heat retrieval |
| Format and Volume | Ready-to-use: 1mL, 3mL, 6mL Concentrated: 0.1mL, 0.2mL, 1 mL |
Download
-
Intended Use
-
Specifications
Related Product
